Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00670293 · ClinicalTrials.gov registry record
Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa
A clinical trial, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 50
- Enrollment target
NCT00670293: Completed study, sponsored by New York State Psychiatric Institute.
NCT00670293 is a clinical trial that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00670293 has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study will use positron emission tomography imaging to investigate changes in dopamine systems in people with anorexia nervosa before and after weight restoration.
Interventions
- DRUG Methylphenidate
- PROCEDURE Magnetic Resonance Imaging (MRI) scan
- RADIATION Positron Emission Tomography (PET) using [11C]raclopride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-07 |
| Est. Completion | 2015-12 |
What the finished NCT00670293 record still lists
NCT00670293 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Methylphenidate is the first listed.
NCT00670293 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00670293 about?
NCT00670293 is a clinical study titled "Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa". This study will use positron emission tomography imaging to investigate changes in dopamine systems in people with anorexia nervosa before and after weight restoration.
What is the current status of trial NCT00670293?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2008-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00670293?
The interventions under investigation include: Methylphenidate (DRUG), Magnetic Resonance Imaging (MRI) scan (PROCEDURE), Positron Emission Tomography (PET) using [11C]raclopride (RADIATION).
Who is sponsoring clinical trial NCT00670293?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia